Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Kitano

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|January 14, 2010
Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancerKazuhiro Yanagihara, Kenichi Yoshimura, Miyuki Niimi, et al.
International Journal of Hematology|October 27, 2021
Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemiaSho Shibata, Shojiro Inano, Mizuki Watanabe, et al.
Cancer Epidemiology|March 24, 2010
Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathyMasashi Kanai, Akira Yoshioka, Shiro Tanaka, et al.
Oncology|December 21, 2006
Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literatureTakayoshi Kiba, Tsutomu Nishimura, Shigemi Matsumoto, et al.
Scientific Reports|December 9, 2020
Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapiesMari Morita-Fujita, Yasuyuki Arai, Satoshi Yoshioka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2013
Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover studyHiroki Nagai, Toshiyuki Kitano, Takafumi Nishimura, et al.
Pharmaceutical Research|April 17, 2019
Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin's LymphomaAtushi Yonezawa, Yuki Otani, Toshiyuki Kitano, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Transplantation and Cellular Therapy|June 12, 2026
Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood TransplantationNaoki Okada, Hiroyuki Muranushi, Junya Kanda, et al.
Cytotherapy|December 9, 2024
Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantationNaokazu Nakamura, Junya Kanda, Tadakazu Kondo, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 14, 2010
Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancerKazuhiro Yanagihara, Kenichi Yoshimura, Miyuki Niimi, et al.
International Journal of Hematology|October 27, 2021
Identification of an asymptomatic Shwachman-Bodian-Diamond syndrome mutation in a patient with acute myeloid leukemiaSho Shibata, Shojiro Inano, Mizuki Watanabe, et al.
Cancer Epidemiology|March 24, 2010
Associations between glutathione S-transferase pi Ile105Val and glyoxylate aminotransferase Pro11Leu and Ile340Met polymorphisms and early-onset oxaliplatin-induced neuropathyMasashi Kanai, Akira Yoshioka, Shiro Tanaka, et al.
Oncology|December 21, 2006
Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literatureTakayoshi Kiba, Tsutomu Nishimura, Shigemi Matsumoto, et al.
Scientific Reports|December 9, 2020
Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapiesMari Morita-Fujita, Yasuyuki Arai, Satoshi Yoshioka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2013
Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover studyHiroki Nagai, Toshiyuki Kitano, Takafumi Nishimura, et al.
Pharmaceutical Research|April 17, 2019
Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin's LymphomaAtushi Yonezawa, Yuki Otani, Toshiyuki Kitano, et al.
Future Oncology (London, England)|February 29, 2024
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)Yu Abe, Shiro Kubonishi, Masaki Ri, et al.
Transplantation and Cellular Therapy|June 12, 2026
Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood TransplantationNaoki Okada, Hiroyuki Muranushi, Junya Kanda, et al.
Cytotherapy|December 9, 2024
Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantationNaokazu Nakamura, Junya Kanda, Tadakazu Kondo, et al.
Pageof 8